Attempts with inhibitors of MMPs have already been successful in a treatment of periodontitis [52]; therefore, there is a rational possibility that selective inhibitors of MMP-9 could find application also in the treatment of IBD. Here, MMP9 is linked to irritable bowel syndrome.